Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Nov;107(3):777–784. doi: 10.1111/j.1476-5381.1992.tb14523.x

A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.

J M Hall 1, J M Flowers 1, I K Morton 1
PMCID: PMC1907736  PMID: 1282072

Abstract

1. We have estimated potencies of tachykinin receptor agonist and antagonist analogues in order to determine the recognition characteristics of tachykinin receptors mediating phasic contractile responses of the rat isolated urinary bladder in vitro. 2. The NK1-selective synthetic agonists, substance P methyl ester and GR73632, the synthetic NK2-selective agonists [beta-Ala8]-NKA(4-10) and GR64349, and the mammalian tachykinins, neurokinin A and neurokinin B, were assayed relative to substance P and were found to be approximately equipotent. The NK3-selective agonist, senktide, was inactive (10 microM). 3. Potencies of all these agonists were not significantly different (P > 0.05) when experiments were carried out in the presence of the neutral endopeptidase inhibitor, phosphoramidon, and the kininase II inhibitor, enalaprilat (both 1 microM). 4. The NK1-selective antagonist, GR82334, inhibited responses to substance P methyl ester in a competitive manner in the rat urinary bladder and the rat ileum, and also in the guinea-pig ileum. Markedly different pKB estimates were obtained in the rat bladder (6.38) and rat ileum (6.56) compared to the guinea-pig ileum (7.42). GR82334 (3 microM) was inactive against responses of the rat bladder to [beta-Ala8]-NKA(4-10). 5. The NK1-selective antagonist (+/-)-CP-96,345 also inhibited responses of the rat bladder and guinea-pig ileum to substance P methyl ester; however, in the rat bladder at 1 microM, this antagonist reversibly inhibited responses both to the NK2-selective agonist [beta-Ala8]-NKA(4-10) and to the muscarinic agonist carbachol (P < or = 0.01), thus showing evidence of some non-selective depressant actions.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
777

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beresford I. J., Birch P. J., Hagan R. M., Ireland S. J. Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345. Br J Pharmacol. 1991 Oct;104(2):292–293. doi: 10.1111/j.1476-5381.1991.tb12423.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Braga M. F., Anderson A. J., Harvey A. L., Rowan E. G. Apparent block of K+ currents in mouse motor nerve terminals by tetrodotoxin, mu-conotoxin and reduced external sodium. Br J Pharmacol. 1992 May;106(1):91–94. doi: 10.1111/j.1476-5381.1992.tb14298.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burcher E., Buck S. H. Multiple tachykinin binding sites in hamster, rat and guinea-pig urinary bladder. Eur J Pharmacol. 1986 Sep 9;128(3):165–177. doi: 10.1016/0014-2999(86)90763-6. [DOI] [PubMed] [Google Scholar]
  4. Cascieri M. A., Goldenberg M. M., Liang T. Biological activity of substance P methyl ester. Mol Pharmacol. 1981 Nov;20(3):457–459. [PubMed] [Google Scholar]
  5. Demolle D., Boeynaems J. M. Cholera and pertussis toxins amplify prostacyclin synthesis in aortic smooth muscle cells. Br J Pharmacol. 1989 Nov;98(3):717–720. doi: 10.1111/j.1476-5381.1989.tb14597.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Erspamer G. F., Negri L., Piccinelli D. The use of preparations of urinary bladder smooth muscle for bioassay of and discrimination between polypeptides. Naunyn Schmiedebergs Arch Pharmacol. 1973;279(1):61–74. doi: 10.1007/BF00502068. [DOI] [PubMed] [Google Scholar]
  7. Gitter B. D., Waters D. C., Bruns R. F., Mason N. R., Nixon J. A., Howbert J. J. Species differences in affinities of non-peptide antagonists for substance P receptors. Eur J Pharmacol. 1991 May 17;197(2-3):237–238. doi: 10.1016/0014-2999(91)90532-u. [DOI] [PubMed] [Google Scholar]
  8. Hagan R. M., Ireland S. J., Jordan C. C., Beresford I. J., Deal M. J., Ward P. Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin function. Neuropeptides. 1991 Jun;19(2):127–135. doi: 10.1016/0143-4179(91)90142-6. [DOI] [PubMed] [Google Scholar]
  9. Hall J. M., Fox A. J., Morton I. K. Peptidase activity as a determinant of agonist potencies in some smooth muscle preparations. Eur J Pharmacol. 1990 Feb 6;176(2):127–134. doi: 10.1016/0014-2999(90)90520-g. [DOI] [PubMed] [Google Scholar]
  10. Hall J. M., Morton I. K. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens. Br J Pharmacol. 1991 Feb;102(2):511–517. doi: 10.1111/j.1476-5381.1991.tb12202.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hershey A. D., Polenzani L., Woodward R. M., Miledi R., Krause J. E. Molecular and genetic characterization, functional expression, and mRNA expression patterns of a rat substance P receptor. Ann N Y Acad Sci. 1991;632:63–78. doi: 10.1111/j.1749-6632.1991.tb33095.x. [DOI] [PubMed] [Google Scholar]
  12. Lecci A., Giuliani S., Patacchini R., Viti G., Maggi C. A. Role of NK1 tachykinin receptors in thermonociception: effect of (+/-)-CP 96,345, a non-peptide substance P antagonist, on the hot plate test in mice. Neurosci Lett. 1991 Aug 19;129(2):299–302. doi: 10.1016/0304-3940(91)90485-c. [DOI] [PubMed] [Google Scholar]
  13. Maggi C. A., Giuliani S., Santicioli P., Abelli L., Regoli D., Meli A. Further studies on the mechanisms of the tachykinin-induced activation of micturition reflex in rats: evidence for the involvement of the capsaicin-sensitive bladder mechanoreceptors. Eur J Pharmacol. 1987 Apr 14;136(2):189–205. doi: 10.1016/0014-2999(87)90711-4. [DOI] [PubMed] [Google Scholar]
  14. Maggi C. A., Giuliani S., Santicioli P., Regoli D., Meli A. Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors. J Auton Pharmacol. 1987 Mar;7(1):11–32. doi: 10.1111/j.1474-8673.1987.tb00130.x. [DOI] [PubMed] [Google Scholar]
  15. Maggi C. A., Meli A. The role of neuropeptides in the regulation of the micturition reflex. J Auton Pharmacol. 1986 Jun;6(2):133–162. doi: 10.1111/j.1474-8673.1986.tb00640.x. [DOI] [PubMed] [Google Scholar]
  16. Maggi C. A., Parlani M., Astolfi M., Santicioli P., Rovero P., Abelli L., Somma V., Giuliani S., Regoli D., Patacchini R. Neurokinin receptors in the rat lower urinary tract. J Pharmacol Exp Ther. 1988 Jul;246(1):308–315. [PubMed] [Google Scholar]
  17. Maggi C. A., Patacchini R., Giuliani S., Rovero P., Dion S., Regoli D., Giachetti A., Meli A. Competitive antagonists discriminate between NK2 tachykinin receptor subtypes. Br J Pharmacol. 1990 Jul;100(3):589–592. doi: 10.1111/j.1476-5381.1990.tb15851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Maggi C. A., Patacchini R., Santicioli P., Giuliani S. Tachykinin antagonists and capsaicin-induced contraction of the rat isolated urinary bladder: evidence for tachykinin-mediated cotransmission. Br J Pharmacol. 1991 Jun;103(2):1535–1541. doi: 10.1111/j.1476-5381.1991.tb09823.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Masu Y., Nakayama K., Tamaki H., Harada Y., Kuno M., Nakanishi S. cDNA cloning of bovine substance-K receptor through oocyte expression system. 1987 Oct 29-Nov 4Nature. 329(6142):836–838. doi: 10.1038/329836a0. [DOI] [PubMed] [Google Scholar]
  20. McLean S., Ganong A. H., Seeger T. F., Bryce D. K., Pratt K. G., Reynolds L. S., Siok C. J., Lowe J. A., 3rd, Heym J. Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist. Science. 1991 Jan 25;251(4992):437–439. doi: 10.1126/science.1703324. [DOI] [PubMed] [Google Scholar]
  21. Nakanishi S. Mammalian tachykinin receptors. Annu Rev Neurosci. 1991;14:123–136. doi: 10.1146/annurev.ne.14.030191.001011. [DOI] [PubMed] [Google Scholar]
  22. Patacchini R., Astolfi M., Quartara L., Rovero P., Giachetti A., Maggi C. A. Further evidence for the existence of NK2 tachykinin receptor subtypes. Br J Pharmacol. 1991 Sep;104(1):91–96. doi: 10.1111/j.1476-5381.1991.tb12390.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rouissi N., Gitter B. D., Waters D. C., Howbert J. J., Nixon J. A., Regoli D. Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P. Biochem Biophys Res Commun. 1991 Apr 30;176(2):894–901. doi: 10.1016/s0006-291x(05)80270-0. [DOI] [PubMed] [Google Scholar]
  24. Rovero P., Pestellini V., Maggi C. A., Patacchini R., Regoli D., Giachetti A. A highly selective NK-2 tachykinin receptor antagonist containing D-tryptophan. Eur J Pharmacol. 1990 Jan 3;175(1):113–115. doi: 10.1016/0014-2999(90)90161-x. [DOI] [PubMed] [Google Scholar]
  25. Rovero P., Pestellini V., Patacchini R., Giuliani S., Santicioli P., Maggi C. A., Meli A., Giachetti A. A potent and selective agonist for NK-2 tachykinin receptor. Peptides. 1989 May-Jun;10(3):593–595. doi: 10.1016/0196-9781(89)90148-4. [DOI] [PubMed] [Google Scholar]
  26. Shigemoto R., Yokota Y., Tsuchida K., Nakanishi S. Cloning and expression of a rat neuromedin K receptor cDNA. J Biol Chem. 1990 Jan 15;265(2):623–628. [PubMed] [Google Scholar]
  27. Snider R. M., Constantine J. W., Lowe J. A., 3rd, Longo K. P., Lebel W. S., Woody H. A., Drozda S. E., Desai M. C., Vinick F. J., Spencer R. W. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science. 1991 Jan 25;251(4992):435–437. doi: 10.1126/science.1703323. [DOI] [PubMed] [Google Scholar]
  28. Takeda Y., Krause J. E. Pharmacological and molecular biological studies on the diversity of rat tachykinin NK-2 receptor subtypes in rat CNS, duodenum, vas deferens, and urinary bladder. Ann N Y Acad Sci. 1991;632:479–482. doi: 10.1111/j.1749-6632.1991.tb33163.x. [DOI] [PubMed] [Google Scholar]
  29. Watson S. P., Sandberg B. E., Hanley M. R., Iversen L. L. Tissue selectivity of substance P alkyl esters: suggesting multiple receptors. Eur J Pharmacol. 1983 Jan 28;87(1):77–84. doi: 10.1016/0014-2999(83)90052-3. [DOI] [PubMed] [Google Scholar]
  30. Wormser U., Laufer R., Hart Y., Chorev M., Gilon C., Selinger Z. Highly selective agonists for substance P receptor subtypes. EMBO J. 1986 Nov;5(11):2805–2808. doi: 10.1002/j.1460-2075.1986.tb04571.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yokota Y., Sasai Y., Tanaka K., Fujiwara T., Tsuchida K., Shigemoto R., Kakizuka A., Ohkubo H., Nakanishi S. Molecular characterization of a functional cDNA for rat substance P receptor. J Biol Chem. 1989 Oct 25;264(30):17649–17652. [PubMed] [Google Scholar]
  32. van Giersbergen P. L., Shatzer S. A., Henderson A. K., Lai J., Nakanishi S., Yamamura H. I., Buck S. H. Characterization of a tachykinin peptide NK2 receptor transfected into murine fibroblast B82 cells. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1661–1665. doi: 10.1073/pnas.88.5.1661. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES